Currently submitted to: Interactive Journal of Medical Research
Date Submitted: Apr 18, 2026
Open Peer Review Period: Apr 20, 2026 - Jun 15, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Impact of Elevated Blood Pressure Targets on Splanchnic Ischemia and Mortality in Septic Resuscitation: A Systematic Review
ABSTRACT
Background:
Sepsis affects nearly 20 million individuals annually, with hemodynamic resuscitation central to its management. While guidelines recommend a MAP target of 65 mmHg, the optimal threshold remains debated.
Objective:
This systematic review evaluates the effect of elevated MAP targets on mortality, splanchnic perfusion, renal outcomes, and vasoactive agent toxicity in septic resuscitation.
Methods:
Following PRISMA 2020 guidelines, we systematically searched PubMed, Embase, and Cochrane databases for studies comparing higher versus standard MAP targets in septic shock patients. Ten studies were included encompassing randomized controlled trials and observational cohorts. Data were synthesized narratively, with a random-effects meta-analysis performed for 28-day mortality. Study quality was assessed using RoB 2 and Newcastle-Ottawa Scale.
Results:
Ten studies enrolling 2,089 patients were included. No randomized trial demonstrated a statistically significant mortality benefit from elevated MAP targets, with pooled meta-analysis confirming no significant difference between higher and standard MAP groups (OR 1.16; 95% CI 0.92–1.46; P = 0.21; I² = 0%). Direct physiological evidence consistently demonstrated that MAP augmentation above 65 mmHg improves microcirculatory parameters without improving splanchnic perfusion, lactate clearance, or microcirculatory flow. Observational evidence identified a renal-protective MAP zone of 72–75 mmHg specifically in patients with chronic hypertension, chronic kidney disease, and early AKI. Vasopressor load emerged as the strongest independent predictor of multiorgan complications and mortality, surpassing MAP level itself. Elevated MAP targets were consistently associated with higher rates of atrial fibrillation and overall adverse events across multiple studies.
Conclusions:
Elevated MAP targets above 65 mmHg confer no mortality or perfusion benefit in unselected septic shock populations. Individualized MAP targeting in high-risk subgroups and vasopressor-sparing strategies warrant prioritization in future research.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.